SAUDI GERMAN HEALTH

Middle East Healthcare Company

4009StocksTadawulHealthcare

Financials

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Ratios

1-5

	CurrentMar 10, 2026	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022
Market & Price
Market Capitalization	3.14B	3.00B	6.32B	8.13B	2.34B
Market Cap Growth	-47.5%	-52.6%	-22.2%	+247.0%	-19.6%
Enterprise Value	5.71B	5.38B	8.80B	10.54B	4.54B
Last Close Price	34.10	32.56	68.11	87.54	25.23
Valuation Multiples
Forward PE (Next 12M Est.)	18.31	10.52	22.96	32.62	24.51
PE Ratio	18.73	9.93	22.42	476.99	31.16
PEG Ratio	—	1.27	0.74	1.16	1.35
PS Ratio	1.00	0.97	2.19	3.06	1.09
PB Ratio	1.63	1.56	3.78	5.95	1.66
P/TBV Ratio	1.73	1.65	4.00	6.31	1.73
P/FCF Ratio	38.43	33.51	21.42	—	—
P/OCF Ratio	5.85	5.50	8.26	42.53	30.81
EV/Sales Ratio	1.82	1.73	3.05	3.97	2.11
EV/EBITDA Ratio	12.23	8.96	14.00	21.17	16.82
EV/EBIT Ratio	23.93	13.88	19.97	32.53	32.35
EV/FCF Ratio	69.93	60.10	29.83	—	—
Leverage & Capital
Debt / Equity Ratio	1.32	1.32	1.47	1.82	1.59
Debt / EBITDA Ratio	5.29	4.10	3.81	4.86	7.87
Debt / FCF Ratio	31.15	28.44	8.35	—	—
Net Debt / Equity Ratio	1.31	1.31	1.44	1.79	1.58
Net Debt / EBITDA Ratio	5.42	4.20	3.84	4.90	8.24
Net Debt / FCF Ratio	30.82	28.15	8.18	-63.35	-12.82
Efficiency & Liquidity
Asset Turnover	—	0.59	0.56	0.55	0.51
Inventory Turnover	—	29.76	25.16	14.69	9.71
Quick Ratio	—	1.40	1.58	1.10	1.01
Current Ratio	—	1.55	1.72	1.19	1.20
Returns & Yields
Return on Equity (ROE)	—	+17.2%	+18.7%	+1.5%	+5.3%
Return on Assets (ROA)	—	+4.6%	+5.4%	+4.2%	+2.1%
Return on Invested Capital (ROIC)	+5.2%	+8.6%	+10.2%	+0.9%	+3.6%
Return on Capital Employed (ROCE)	—	+9.7%	+11.4%	+10.8%	+4.9%
Earnings Yield	+5.3%	+10.1%	+4.5%	+0.2%	+3.2%
FCF Yield	+2.6%	+3.0%	+4.7%	-0.5%	-7.4%
Dividend Yield	+1.5%	—	+0.7%	—	—
Payout Ratio	+27.5%	+15.2%	—	—	—
Total Shareholder Return	+1.5%	—	+0.7%	—	—

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Ratios

1-5

	CurrentMar 10, 2026	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022
Market & Price
Market Capitalization	3.14B	3.00B	6.32B	8.13B	2.34B
Market Cap Growth	-47.5%	-52.6%	-22.2%	+247.0%	-19.6%
Enterprise Value	5.71B	5.38B	8.80B	10.54B	4.54B
Last Close Price	34.10	32.56	68.11	87.54	25.23
Valuation Multiples
Forward PE (Next 12M Est.)	18.31	10.52	22.96	32.62	24.51
PE Ratio	18.73	9.93	22.42	476.99	31.16
PEG Ratio	—	1.27	0.74	1.16	1.35
PS Ratio	1.00	0.97	2.19	3.06	1.09
PB Ratio	1.63	1.56	3.78	5.95	1.66
P/TBV Ratio	1.73	1.65	4.00	6.31	1.73
P/FCF Ratio	38.43	33.51	21.42	—	—
P/OCF Ratio	5.85	5.50	8.26	42.53	30.81
EV/Sales Ratio	1.82	1.73	3.05	3.97	2.11
EV/EBITDA Ratio	12.23	8.96	14.00	21.17	16.82
EV/EBIT Ratio	23.93	13.88	19.97	32.53	32.35
EV/FCF Ratio	69.93	60.10	29.83	—	—
Leverage & Capital
Debt / Equity Ratio	1.32	1.32	1.47	1.82	1.59
Debt / EBITDA Ratio	5.29	4.10	3.81	4.86	7.87
Debt / FCF Ratio	31.15	28.44	8.35	—	—
Net Debt / Equity Ratio	1.31	1.31	1.44	1.79	1.58
Net Debt / EBITDA Ratio	5.42	4.20	3.84	4.90	8.24
Net Debt / FCF Ratio	30.82	28.15	8.18	-63.35	-12.82
Efficiency & Liquidity
Asset Turnover	—	0.59	0.56	0.55	0.51
Inventory Turnover	—	29.76	25.16	14.69	9.71
Quick Ratio	—	1.40	1.58	1.10	1.01
Current Ratio	—	1.55	1.72	1.19	1.20
Returns & Yields
Return on Equity (ROE)	—	+17.2%	+18.7%	+1.5%	+5.3%
Return on Assets (ROA)	—	+4.6%	+5.4%	+4.2%	+2.1%
Return on Invested Capital (ROIC)	+5.2%	+8.6%	+10.2%	+0.9%	+3.6%
Return on Capital Employed (ROCE)	—	+9.7%	+11.4%	+10.8%	+4.9%
Earnings Yield	+5.3%	+10.1%	+4.5%	+0.2%	+3.2%
FCF Yield	+2.6%	+3.0%	+4.7%	-0.5%	-7.4%
Dividend Yield	+1.5%	—	+0.7%	—	—
Payout Ratio	+27.5%	+15.2%	—	—	—
Total Shareholder Return	+1.5%	—	+0.7%	—	—